Miglustat G.L. Pharma je indikovaný na perorálnu liečbu 1. typu Gaucherovej choroby , mierneho až stredného stupňa u dospelých pacientov. Miglustat G.L. Pharma sa môže použiť iba na terapiu pacientov, pre ktorých nie je vhodná substitučná enzýmová terapia.
Miglustat G.L. Pharma je indikovaný na liečbu progredujúcich neurologických symptómov dospelých a pediatrických pacientov s Niemannovou-Pickovou chorobou typu C.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information